Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Tomorrow

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Feb 20, 2024 10:10am

152 Views

Post# 35888708

Tomorrow

Tomorow is Q4 + Year End. The market is not anticipating much of upside surprise. Hope the EDITDA story is still alive and kicking. I'd be surprise they can grow sales by raising the price again this year tahnks to the democrats. Anyway, if they fail to show good stable business tomorrow I predict management changes before AGM.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals